News Image

Investors should take note of NYSE:CI, a growth stock that remains attractively priced.

By Mill Chart

Last update: Mar 18, 2024

Our stock screener has singled out THE CIGNA GROUP (NYSE:CI) as an attractive growth opportunity. NYSE:CI is demonstrating remarkable growth potential while maintaining strong financial indicators, making it a reasonably priced option. We'll explore this further.

Exploring NYSE:CI's Growth

To evaluate a stock's growth potential, ChartMill utilizes a Growth Rating on a scale of 0 to 10. This comprehensive assessment considers various growth aspects, including historical and estimated EPS and revenue growth. NYSE:CI has achieved a 7 out of 10:

  • CI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.05%, which is quite good.
  • The Earnings Per Share has been growing by 11.91% on average over the past years. This is quite good.
  • Looking at the last year, CI shows a quite strong growth in Revenue. The Revenue has grown by 8.42% in the last year.
  • The Revenue has been growing by 32.15% on average over the past years. This is a very strong growth!
  • CI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.43% yearly.
  • CI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.51% yearly.

How We Gauge Valuation for NYSE:CI

ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NYSE:CI, the assigned 7 reflects its valuation:

  • Based on the Price/Earnings ratio, CI is valued cheaply inside the industry as 88.79% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 25.59. CI is valued slightly cheaper when compared to this.
  • CI's Price/Forward Earnings ratio is rather cheap when compared to the industry. CI is cheaper than 92.24% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CI to the average of the S&P500 Index (22.07), we can say CI is valued slightly cheaper.
  • Based on the Enterprise Value to EBITDA ratio, CI is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • CI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CI is cheaper than 85.34% of the companies in the same industry.
  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CI may justify a higher PE ratio.
  • CI's earnings are expected to grow with 13.35% in the coming years. This may justify a more expensive valuation.

Understanding NYSE:CI's Health Score

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:CI has earned a 5 out of 10:

  • With a decent Altman-Z score value of 2.35, CI is doing good in the industry, outperforming 63.79% of the companies in the same industry.
  • The Debt to FCF ratio of CI is 3.02, which is a good value as it means it would take CI, 3.02 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.02, CI belongs to the top of the industry, outperforming 80.17% of the companies in the same industry.

A Closer Look at Profitability for NYSE:CI

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NYSE:CI has achieved a 6:

  • The Return On Assets of CI (3.38%) is better than 72.41% of its industry peers.
  • CI's Return On Equity of 11.17% is fine compared to the rest of the industry. CI outperforms 76.72% of its industry peers.
  • The Return On Invested Capital of CI (7.65%) is better than 77.59% of its industry peers.
  • The 3 year average ROIC (7.18%) for CI is below the current ROIC(7.65%), indicating increased profibility in the last year.
  • CI's Profit Margin of 2.64% is fine compared to the rest of the industry. CI outperforms 71.55% of its industry peers.
  • CI has a better Operating Margin (4.63%) than 64.66% of its industry peers.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

Our latest full fundamental report of CI contains the most current fundamental analsysis.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

THE CIGNA GROUP

NYSE:CI (4/19/2024, 2:42:03 PM)

After market: 352.39 0 (0%)

352.39

+3.61 (+1.04%)

CI News

News Imagea day ago - Zacks Investment ResearchWhy the Market Dipped But Cigna (CI) Gained Today

Cigna (CI) closed at $348.78 in the latest trading session, marking a +0.78% move from the prior day.

News Imagea day ago - The Business JournalsCigna wins $6M judgment against South Florida health care provider
News Imagea day ago - The Cigna GroupThe Cigna Group Foundation Announces New Grant Program To Address Youth Mental Health Crisis

/PRNewswire/ -- As part of its ongoing commitment to community health and vitality, global health company The Cigna Group (NYSE: CI) today announced a...

News Image3 days ago - InvestorPlace3 Weight-Loss ETFs to Profit From the Obesity Drug Boom

Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.

News Image3 days ago - ChartmillTop S&P500 movers in Tuesday's pre-market session

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

News Image7 days ago - Market News VideoNotable Friday Option Activity: CI, FANG, BYND
News Image8 days ago - The Cigna GroupThe Cigna Group's First Quarter 2024 Earnings Release Details

/PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2024 financial results on Thursday, May 2, 2024, and will host a...

News Image10 days ago - The Cigna GroupThe Cigna Group Named Among Best Employers for Health and Well-Being

/PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) has been recognized for excellence in employee health and well-being by the Business Group on...

News Image10 days ago - The Business JournalsEight Triad OB/GYN practices come back in network with Cigna after dispute with UWH of the Carolinas
News Image11 days ago - ChartmillDon't overlook NYSE:CI—it's a hidden gem with strong fundamentals and an attractive price tag.

THE CIGNA GROUP (NYSE:CI) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

News Image11 days ago - ChartmillFor those who appreciate growth without the sticker shock, NYSE:CI is worth considering.

Looking for growth without the hefty price tag? Consider THE CIGNA GROUP (NYSE:CI).

News Image14 days ago - Investor's Business DailyMarket Rally Under Pressure; Tesla, Humana In Focus: Weekly Review

The indexes and leading stocks are generally holding key levels.

CI Links
Follow us for more